Free Trial

Johnson & Johnson (JNJ) Competitors

Johnson & Johnson logo
$169.62 +0.52 (+0.31%)
Closing price 07/24/2025 03:59 PM Eastern
Extended Trading
$169.36 -0.26 (-0.15%)
As of 06:32 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

JNJ vs. ISRG, MRNA, NVAX, ABBV, BRK.B, LLY, MRK, PFE, PG, and XOM

Should you be buying Johnson & Johnson stock or one of its competitors? The main competitors of Johnson & Johnson include Intuitive Surgical (ISRG), Moderna (MRNA), Novavax (NVAX), AbbVie (ABBV), Berkshire Hathaway (BRK.B), Eli Lilly and Company (LLY), Merck & Co., Inc. (MRK), Pfizer (PFE), Procter & Gamble (PG), and Exxon Mobil (XOM).

Johnson & Johnson vs. Its Competitors

Intuitive Surgical (NASDAQ:ISRG) and Johnson & Johnson (NYSE:JNJ) are both large-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, media sentiment, valuation, institutional ownership, earnings, profitability, risk and analyst recommendations.

Intuitive Surgical has a net margin of 28.51% compared to Johnson & Johnson's net margin of 25.00%. Johnson & Johnson's return on equity of 33.07% beat Intuitive Surgical's return on equity.

Company Net Margins Return on Equity Return on Assets
Intuitive Surgical28.51% 14.56% 12.93%
Johnson & Johnson 25.00%33.07%13.16%

In the previous week, Johnson & Johnson had 36 more articles in the media than Intuitive Surgical. MarketBeat recorded 128 mentions for Johnson & Johnson and 92 mentions for Intuitive Surgical. Johnson & Johnson's average media sentiment score of 1.28 beat Intuitive Surgical's score of 1.17 indicating that Johnson & Johnson is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Intuitive Surgical
58 Very Positive mention(s)
8 Positive mention(s)
14 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive
Johnson & Johnson
103 Very Positive mention(s)
5 Positive mention(s)
9 Neutral mention(s)
4 Negative mention(s)
0 Very Negative mention(s)
Positive

Intuitive Surgical currently has a consensus target price of $592.05, indicating a potential upside of 21.17%. Johnson & Johnson has a consensus target price of $174.50, indicating a potential upside of 2.88%. Given Intuitive Surgical's higher possible upside, equities research analysts plainly believe Intuitive Surgical is more favorable than Johnson & Johnson.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Intuitive Surgical
1 Sell rating(s)
5 Hold rating(s)
14 Buy rating(s)
0 Strong Buy rating(s)
2.65
Johnson & Johnson
0 Sell rating(s)
9 Hold rating(s)
9 Buy rating(s)
2 Strong Buy rating(s)
2.65

Johnson & Johnson has higher revenue and earnings than Intuitive Surgical. Johnson & Johnson is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Intuitive Surgical$8.35B20.97$2.32B$6.8271.64
Johnson & Johnson$88.82B4.59$14.07B$9.3518.14

83.6% of Intuitive Surgical shares are held by institutional investors. Comparatively, 69.6% of Johnson & Johnson shares are held by institutional investors. 0.7% of Intuitive Surgical shares are held by insiders. Comparatively, 0.2% of Johnson & Johnson shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Intuitive Surgical has a beta of 1.64, suggesting that its share price is 64% more volatile than the S&P 500. Comparatively, Johnson & Johnson has a beta of 0.41, suggesting that its share price is 59% less volatile than the S&P 500.

Summary

Intuitive Surgical and Johnson & Johnson tied by winning 8 of the 16 factors compared between the two stocks.

Get Johnson & Johnson News Delivered to You Automatically

Sign up to receive the latest news and ratings for JNJ and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding JNJ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

JNJ vs. The Competition

MetricJohnson & JohnsonLarge Cap Pharma IndustryMedical SectorNYSE Exchange
Market Cap$406.87B$257.96B$5.73B$21.15B
Dividend Yield3.08%2.82%4.60%3.58%
P/E Ratio18.1427.9327.9827.76
Price / Sales4.595.09447.4658.49
Price / Cash12.8914.1136.5523.00
Price / Book5.7117.978.654.67
Net Income$14.07B$8.49B$3.24B$993.85M
7 Day Performance3.65%3.75%3.69%1.48%
1 Month Performance11.35%3.75%10.34%5.79%
1 Year Performance6.21%-5.54%34.36%11.41%

Johnson & Johnson Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
JNJ
Johnson & Johnson
4.8288 of 5 stars
$169.62
+0.3%
$174.50
+2.9%
+8.5%$406.87B$88.82B18.14138,100Trending News
Analyst Upgrade
ISRG
Intuitive Surgical
4.6974 of 5 stars
$518.31
-0.1%
$592.86
+14.4%
+7.6%$185.67B$8.35B75.9615,638Trending News
Earnings Report
Analyst Forecast
MRNA
Moderna
4.2558 of 5 stars
$31.55
+0.9%
$46.61
+47.8%
-71.2%$12.17B$3.24B-3.605,800Upcoming Earnings
Analyst Forecast
NVAX
Novavax
4.3034 of 5 stars
$7.01
+0.1%
$17.00
+142.7%
-50.4%$1.13B$682.16M2.641,990News Coverage
Analyst Forecast
Options Volume
Gap Up
ABBV
AbbVie
4.8831 of 5 stars
$186.10
-1.7%
$211.29
+13.5%
+8.3%$328.66B$56.33B79.1855,000Trending News
Upcoming Earnings
BRK.B
Berkshire Hathaway
0.6514 of 5 stars
$477.14
+0.7%
$520.00
+9.0%
+11.3%$1.03T$371.43B12.72392,400
LLY
Eli Lilly and Company
4.9796 of 5 stars
$764.66
-0.9%
$1,012.56
+32.4%
-6.4%$724.88B$49.00B62.2347,000Trending News
MRK
Merck & Co., Inc.
4.9962 of 5 stars
$79.48
-0.6%
$108.69
+36.8%
-33.1%$199.62B$64.17B11.5775,000Positive News
Upcoming Earnings
Dividend Announcement
PFE
Pfizer
4.9781 of 5 stars
$24.47
0.0%
$28.55
+16.7%
-15.4%$139.15B$63.63B17.7481,000Trending News
Options Volume
PG
Procter & Gamble
4.8084 of 5 stars
$155.71
+0.4%
$176.84
+13.6%
-5.5%$364.97B$83.93B24.71108,000Positive News
Upcoming Earnings
XOM
Exxon Mobil
4.9396 of 5 stars
$108.37
+0.6%
$125.42
+15.7%
-3.6%$467.22B$349.59B14.3861,000Trending News
Upcoming Earnings
Analyst Revision

Related Companies and Tools


This page (NYSE:JNJ) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners